The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma

Published:2019-12-11 Issue: Volume:25 Page:9458-9470
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Xu Wen-Hao¹,Shi Shen-Nan²,Wang Jun¹,Xu Yue³,Tian Xi¹,Wan Fang-Ning¹,Cao Da-Long¹,Qu Yuan-Yuan¹,Zhang Hai-Liang¹,Ye Ding-Wei¹

Affiliation:

1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China (mainland)

2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (mainland)

3. Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Chemical Synthesis of Serine Protease Inhibitor Kazal‐type 13 (SPINK13) Glycoform by a Combined Method with Glycan Insertion Strategy and Fast‐Flow Fmoc SPPS**;Chemistry – A European Journal;2023-06-09

2. Understanding the phenotypic and genetic background of the lactose content in Sarda dairy sheep;Journal of Dairy Science;2023-05

3. A Kazal-type serine protease inhibitor mediates innate immunity in wild silkworm Actias selene Hübner;Journal of Biosciences;2022-06

4. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma;Disease Markers;2022-03-08

5. SPINKs in Tumors: Potential Therapeutic Targets;Frontiers in Oncology;2022-02-11